MALAT1 and nasopharyngeal carcinoma: Virtually, MALAT1 expression was observably raised in diversified neoplasms, including nasopharyngeal carcinoma,9 esophageal cancer,10 nasopharyngeal carcinoma,11 colorectal cancer,12 liver cancer,13 breast cancer,14 oral squamous cell carcinoma,15 and cervical cancer,16 which suggested that targeting MALAT1 might be fruitful in dampening neoplastic growth and improving tumor treatment.